IMPORTANCE OF HEMODYNAMIC-RESPONSE TO THERAPY IN PREDICTING SURVIVAL WITH EJECTION FRACTION LESS-THAN-OR-EQUAL-TO-20-PERCENT SECONDARY TO ISCHEMIC OR NONISCHEMIC DILATED CARDIOMYOPATHY

被引:279
作者
STEVENSON, LW [1 ]
TILLISCH, JH [1 ]
HAMILTON, M [1 ]
LUU, M [1 ]
CHELIMSKYFALLICK, C [1 ]
MORIGUCHI, J [1 ]
KOBASHIGAWA, J [1 ]
WALDEN, J [1 ]
机构
[1] AMER HEART ASSOC, LOS ANGELES, CA USA
关键词
D O I
10.1016/0002-9149(90)91166-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To identify patients with left ventricular ejection fractions ≤ 20% who are likely to survive on tailored medical therapy after referral to transplantation, this study of 152 patients addressed the hypotheses that (1) severely elevated filling pressures initially measured at referral would not necessarily predict poor outcome, (2) survival would be best when low pulmonary wedge pressures could be achieved with therapy tailored for hemodynamic goals, and (3) coronary artery disease would be an independent risk factor for early mortality. Despite an average initial ejection fraction of 0.15, cardiac index of 2.0 liters/min/m2 and pulmonary artery wedge pressure of 28 mm Hg, the actuarial survival with tailored therapy was 63% at 1 year, with 34 of 41 (83%) deaths occurring suddenly. Survival was not related to initial filling pressure elevation, but was best predicted by the pulmonary artery wedge pressures during therapy; patients achieving pressure of ≤ 16 mm Hg had 1-year survival of 83 vs 38% (p = 0.0001). The other independent predictors were serum sodium and coronary artery disease. Patients with high filling pressures during therapy and coronary artery disease had 21% survival at 1 year. Survival after referral to transplantation with an ejection fraction ≤ 20% is better than previously described. Patients in whom left ventricular filling pressures cannot be adequately reduced by tailored therapy, particularly if coronary artery disease is present, should be considered for early transplantation. © 1990.
引用
收藏
页码:1348 / 1354
页数:7
相关论文
共 30 条
[1]  
COHN JN, 1987, CIRCULATION, V75, P49
[2]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[3]   DETERMINANTS OF CLINICAL-RESPONSE AND SURVIVAL IN PATIENTS WITH CONGESTIVE HEART-FAILURE TREATED WITH CAPTOPRIL [J].
CREAGER, MA ;
FAXON, DP ;
HALPERIN, JL ;
MELIDOSSIAN, CD ;
MCCABE, CH ;
SCHICK, EC ;
RYAN, TJ .
AMERICAN HEART JOURNAL, 1982, 104 (05) :1147-1154
[4]  
DIXON WJ, 1985, BMDP STATISTICAL SOF, P557
[5]  
EVANS RW, 1986, JAMA-J AM MED ASSOC, V255, P1892
[6]  
FRAGOMENI LS, 1988, J HEART TRANSPLANT, V7, P249
[7]   SURVIVAL IN MEN WITH SEVERE CHRONIC LEFT-VENTRICULAR FAILURE DUE TO EITHER CORONARY HEART-DISEASE OR IDIOPATHIC DILATED CARDIOMYOPATHY [J].
FRANCIOSA, JA ;
WILEN, M ;
ZIESCHE, S ;
COHN, JN .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (05) :831-836
[8]   PREDICTORS OF TOTAL MORTALITY AND SUDDEN-DEATH IN MILD TO MODERATE HEART-FAILURE [J].
GRADMAN, A ;
DEEDWANIA, P ;
CODY, R ;
MASSIE, B ;
PACKER, M ;
PITT, B ;
GOLDSTEIN, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (03) :564-570
[9]   ACUTE REDUCTION OF ATRIAL OVERLOAD DURING VASODILATOR AND DIURETIC THERAPY IN ADVANCED CONGESTIVE HEART-FAILURE [J].
HAMILTON, MA ;
STEVENSON, LW ;
CHILD, JS ;
MORIGUCHI, JD ;
WOO, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (18) :1209-1212
[10]  
HIRSCH AT, 1987, CIRCULATION, V75, P36